Founded in 1999, Actavis Inc., also known as Actavis Pharma Inc., is a global pharmaceutical company that develops manufactures and markets a wide range of branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. The company also develops specialty pharmaceuticals. The company’s global headquarters were in Dublin in Ireland. But in the U.S., it is located at 100 Campus Drive Florham Park, NJ 07932. The company changed its name to Allergan PLC in 2015, and later, it sold off one arm, Actavis Generics, to Teva Pharmaceutical Company. However, it is still known as Actavis Inc., in Europe and Canada.

Allergan divides its business into three operating segments: US Specialized Therapeutics, US General Medicine, and International. The company has a commercial presence across approximately 100 jurisdictions. It is headed by Brenton L. Saunders and is listed in the New York Stock Exchange, NASDAQ, London Stock Exchange, and Frankfurt Stock Exchange.

Latest Actavis News

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.